January 11, 2017
Illumina utilised their showcase at the JP Morgan Conference to announce its new DNA sequencers, the NovaSeq 5000 and NovaSeq 6000, promising that by the end of the […]
News, research & analysis from the global Biotechnology industry.
November 29, 2016
[vc_row][vc_column][vc_column_text]The field of CAR-T immunotherapy presents a tantalising idea: reengineering a patient’s immune cells to attack cancer. CAR-T immunotherapy has the potential to revolutionise the way […]
November 9, 2016
[vc_row][vc_column][vc_column_text]The idea of transfusing blood from younger individuals to older individuals has returned to the spotlight following the commencement of clinical trials by US companies Alkahest […]
October 13, 2016
In May 2016 a megamerger between Quintiles, the world’s largest CRO, and healthcare data and consultancy firm IMS was announced, with the combined company branded as […]
September 14, 2016
[vc_row][vc_column][vc_column_text]The American Society of Clinical Oncology (ASCO) recently named cancer immunotherapy as the 2016 Advance of the Year, with President Dr. Julie Vose noting that “no […]
September 8, 2016
Danaher has announced the acquisition of medical diagnostics company Cepheid, bolstering their presence in the Molecular Diagnostics market. Danaher Corporation will pay $53 per share in […]
August 23, 2016
Pharmaceutical giants Pfizer are expanding their cancer portfolio through the $14B acquisition of California-based biopharmaceutical company Medivation. The acquisition follows two recent unsuccessful bids for Medivation […]
August 3, 2016
In order to elucidate the focus of Venture Capital funding in the Biotechnology sector this year, Evolution Analysts have assessed the deals carried out by the […]
July 11, 2016
Bio-Techne Corporation have agreed to acquire California-based molecular pathology company Advanced Cell Diagnostics for $250 million in cash plus additional potential milestone payments of up to […]